Your browser doesn't support javascript.
loading
Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
Stotz, M; Thümmler, D; Schürch, M; Renggli, J-C; Urwyler, A; Pargger, H.
Affiliation
  • Stotz M; Department of Anaesthesia, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland. Stotzm@hotmail.com
Br J Anaesth ; 93(6): 868-71, 2004 Dec.
Article de En | MEDLINE | ID: mdl-15377584
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Complications postopératoires / Syndrome de sevrage / Syndrome malin des neuroleptiques / Antiparkinsoniens Limites: Humans / Male / Middle aged Langue: En Journal: Br J Anaesth Année: 2004 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Royaume-Uni
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Complications postopératoires / Syndrome de sevrage / Syndrome malin des neuroleptiques / Antiparkinsoniens Limites: Humans / Male / Middle aged Langue: En Journal: Br J Anaesth Année: 2004 Type de document: Article Pays d'affiliation: Suisse Pays de publication: Royaume-Uni